Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Amortizatization of Intangibles (2022 - 2025)

Historic Amortizatization of Intangibles for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $2.0 million.

  • Indivior Pharmaceuticals' Amortizatization of Intangibles fell 5000.0% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 2727.27%. This contributed to the annual value of $8.0 million for FY2024, which is 1111.11% down from last year.
  • According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Amortizatization of Intangibles is $2.0 million, which was down 5000.0% from $4.0 million recorded in Q3 2024.
  • In the past 5 years, Indivior Pharmaceuticals' Amortizatization of Intangibles registered a high of $4.0 million during Q3 2024, and its lowest value of $1.0 million during Q3 2023.
  • Its 4-year average for Amortizatization of Intangibles is $2.3 million, with a median of $2.0 million in 2022.
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Amortizatization of Intangibles plummeted by 5000.0% in 2023, and later surged by 30000.0% in 2024.
  • Over the past 4 years, Indivior Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at $2.0 million in 2022, then skyrocketed by 50.0% to $3.0 million in 2023, then surged by 33.33% to $4.0 million in 2024, then tumbled by 50.0% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $4.0 million for Q3 2024, and $2.0 million during Q2 2024.